.png){kind=icon}
返回
Does Semaglutide Use Decrease Complications and Costs Following Total Knee Arthroplasty?
.png){kind=icon}
PRE
AI
DOI：10.1016/j.arth.2023.05.071.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Background: Diabetes mellitus (DM) and obesity are associated with total knee arthroplasty (TKA) complications. Semaglutide, a medication for DM and weight loss, can potentially affect TKA outcomes. This study investigated whether semaglutide use during TKA demonstrates fewer: (1) medical complications; (2) implant-related complications; (3) readmissions; and (4) costs.Methods: A retrospective query was performed using a National database to 2021. Patients undergoing TKA for osteoarthritis with DM and semaglutide use were successfully propensity score-matched to controls semaglutide = 7,051; control = 34,524. Outcomes included 90-day postoperative medical complications, 2-year implant-related complications, 90-day readmissions, in-hospital lengths of stay, and costs. Multivariate logistical regressions calculated odds ratios (ORs), 95% confidence intervals, and P values (P < .003 as significance threshold after Bonferroni correction).Results: Semaglutide cohorts had higher incidence and odds of myocardial infarction (1.0 versus 0.7%; OR 1.49; P = .003), acute kidney injury (4.9 versus 3.9%; OR 1.28; P < .001), pneumonia (2.8 versus 1.7%; OR 1.67; P < .001), and hypoglycemic events (1.9 versus 1.2%; OR 1.55; P < .001), but lower odds of sepsis (0 versus 0.4%; OR 0.23; P < .001). Semaglutide cohorts also had lower odds of prosthetic joint infections (2.1 versus 3.0%; OR 0.70; P < .001) and readmission (7.0 versus 9.4%; OR 0.71; P < .001), and trended toward lower odds of revisions (4.0 versus 4.5%; OR 0.86; P = .02) and 90-day costs ($15,291.66 versus $16,798.46; P = .012). Conclusion: Semaglutide use during TKA decreased risk for sepsis, prosthetic joint infections, and readmissions, but also increased risk for myocardial infarction, acute kidney injury, pneumonia, and hypoglycemic events.(c) 2023 Elsevier Inc. All rights reserved.
Keyword:
semaglutide
total knee arthroplasty
complications
prosthetic joint infections
diabetes mellitus
sepsis
期刊
IF:
3.8
论文数:
1.3W
被引数:
3.2W
机构
引用论文
GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody.png)
ENDOCRINOLOGY
OAAI
ENDOCRINOLOGYIF3.3
OAAI分享收藏Effect of Bariatric Surgery on Risk of Complications After Total Knee Arthroplasty A Randomized Clinical TrialJAMA NETWORK OPENOAAI
JAMA NETWORK OPENIF9.7
OAAI分享收藏
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesSemaglutide与2型糖尿病患者的心血管结局OAAI
OAAI分享收藏
查看更多内容